Covered recipient · General Payments record
BRANDY L YEARY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,123.04
- Reported across 144 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $265.94 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $114.96 | 5 |
| Lilly USA, LLC | $61.82 | 4 |
| Astellas Pharma US Inc | $39.45 | 2 |
| Acerta Pharma LLC | $33.55 | 2 |
| IBSA Pharma Inc. | $16.16 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $25.57 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139268758 | CMS |
| Astellas Pharma US Inc | $13.88 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139402153 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.44 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104421079 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.11 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104458048 | CMS |
| IBSA Pharma Inc. | $16.16 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142984398 | CMS |
| Lilly USA, LLC | $18.04 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136070231 | CMS |
| Lilly USA, LLC | $15.14 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136070233 | CMS |
| Lilly USA, LLC | $15.43 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136074821 | CMS |
| Lilly USA, LLC | $13.21 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136074823 | CMS |
| Novo Nordisk Inc | $20.97 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097080677 | CMS |
| Novo Nordisk Inc | $19.38 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097384599 | CMS |
| Novo Nordisk Inc | $24.76 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097068217 | CMS |
| Novo Nordisk Inc | $21.84 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097279186 | CMS |
| Novo Nordisk Inc | $28.01 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097390426 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.